En Carta Diagnostics secures €1.5M to advance diagnostic kit platform for early Lyme disease detection

Groundbreaking patented molecular diagnostic kit poised to provide game-changing autonomous Lyme detection in minutes

27-May-2024 - En Carta Diagnostics, a deeptech start-up developing rapid Point-of-Care (POC) molecular diagnostics kits, announces €1.5M ($1.63M) in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a prototype diagnostic kit for its ...

Bio-Techne announces new distribution agreement with Thermo Fisher Scientific

07-May-2024 - Bio-Techne Corporation to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, 2024, Bio-Techne will enter into a strategic distribution agreement with Thermo Fisher Scientific in Europe. This partnership marks an important ...

PerkinElmer Completes Acquisition of Oxford Immunotec

12-Mar-2021 - PerkinElmer, Inc. announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in fighting tuberculosis, ...

Merck to manufacture liquid biopsy kits for Swedish start-up

Liquid biopsy kits aim to improve accuracy of cancer diagnosis

19-Feb-2020 - Merck announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits. The kits analyze metabolites deregulated in several cancer types, making diagnoses more accurate. “Both small and large ...

Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

12-Jul-2018 - Gyros Protein Technologies AB and Cygnus Technologies announced they have signed a licensing and supply agreement. Under the agreement, Cygnus Technologies will supply Gyros Protein Technologies with its proprietary reagents for host cell protein analysis, enabling the development of new Gyrolab® ...

Merck Acquires BioControl to Strengthen Position in Food Safety Testing

05-Jan-2017 - Merck announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens growth opportunities for Merck in the food and beverage space; particularly in the U.S. Confidentiality has been agreed on the financial details of the transaction. BioControl’s ...

Agilent Technologies to acquire Multiplicom

22-Dec-2016 - Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a European diagnostics company with state-of-the-art genetic testing technology and products. Multiplicom, headquartered in Niel, ...

SYGNIS AG to receive €1.9 million non-dilutive R&D funding from the Spanish government

28-Oct-2016 - SYGNIS AG announced that the Spanish Ministry of Economy and Competitiveness (MINECO), Department of Research and Development, has granted two soft loans under its prestigious and very competitive RETOS program to fund DNA research projects undertaken by the Company in collaboration with the ...

Agilent Technologies completes acquisition of Seahorse Bioscience

04-Nov-2015 - Agilent Technologies Inc. announced it has completed the acquisition of Seahorse Bioscience, which provides instruments and assay kits for measuring cell metabolism and bioenergetics. Agilent announced its intent to acquire Seahorse on Sept. 9 . Seahorse’s leading technology enables researchers ...

Is the Ebola Virus a Real Threat for Europe and the US?

Frost & Sullivan Life Sciences Senior Research Analyst Sriram Radhakrishnan discusses the available screening options to enable early detection of the virus

11-Aug-2014 - “The Zaire Ebola virus causes a highly contagious and lethal hemorrhagic fever leading to the death of the infected individuals. The recent outbreak of the virus in West Africa has alarmed the world, especially Europe and the US, owing to the geographical speed of the infection spread and high ...